|
SCIENTIFIC PROGRAM Friday, November the 8th, 2019 |
8:30 - 8:50 |
Aldo Pinchera memorial lecture |
|
Chairperson: Paolo Vitti (Pisa) |
|
Epidemiology and secular trends of GO - Petros Perros (Newcastle upon Tyne) |
8:55 - 9:15 |
Symposium 3: anlmal models of GD and GO |
|
Chairpersons: Marian Ludgate (Cardiff), Gerd Krause (Berlin) |
8:55 - 9:15 |
Epitope peptides derived from the TSH receptor as an effective treatment in a mouse model of Graves' disease and GO - Martin Ungerer (Bavaria) |
|
The "English" model - Paul Banga (London) |
9:35 - 9:55 |
The "German" model - Utta Berchner-Pfannshmidt (Essen) |
10:00 - 11:00 |
Oral Presentations 2 |
|
Chairpersons: Katharina Ponto (Mainz), Milos iarkovic (Beigrade) |
11:00 - 11:20 |
Coffee Break |
11:20 - 12:40 |
Symposium 4: ophthalmologlcal controversles and unmet needs |
|
Chairpersons: Kostas Boboridis (Thessanoliki), Co/in Dayan (Cardiff) |
11:20 - 11:40 |
EUGOGO consensus on eye motility assessment - Nicola Curro (Milan) |
11:40 - 12:00 |
Assessment of primary and secondary outcomes of immunosuppressive treatment of active GO - Luigi Bartalena (Varese) |
12:00 - 12:40 |
DEBATE: ls CAS always a reliable tool to define GO activity? |
|
Pro: Lucy Clark (Newcastle upon Tyne) |
|
Cons: Peter Dolman (Vancouver) |
12:40 - 14:15 |
Lunch and Poster viewing |
14:15 - 15:35 |
Symposium 5: from pathogenesis to medical treatment: focus on the TSH receptor |
|
Chairpersons: George Kahaly (Mainz), Terry Smith (Ann Arbour) |
14:15 - 14:35 |
TSH receptor and signaling pathways - Gerd Krause (Berlin) |
14:35 - 14:55 |
TSH receptor and lgF-1 receptor interactions - Marvin Gershengorn (Bethesda) |
14:55 - 15.15 |
Small molecules antagonists as potential new agents for therapeutic targeting of the TSH receptor - Susanne Neumann (Bethesda) |
15:15 - 15:35 |
TSH receptor monoclonal blocking antibodies - Wisia Furmaniak (Cardiff) |
15:40 - 16:40 |
Symposium 6 (Part 1 ): old and novel treatment modalltles |
|
Chairpersons: Mario Sa/vi (Milan), Nichole Fichter (O/ten) |
15:40 - 16:00 |
lntravenous glucocorticoids - C/audio Marcocci (Pisa) |
16:00 - 16:20 |
Selenium - Michele Marino (Pisa) |
16:20 - 16:40 |
Mycophenolate (The MINGO Study) - George Kahaly (Mainz) |
16:40 - 17:00 |
Coffee Break |
17:00 - 18:35 |
Symposium 6 (Part 2): Old and novel treatment modallties |
|
Chairpersons: Simon Pearce (Newcastle upon Tyne), Anja Eckstein (Essen) |
17:00 - 17:20 |
Combined immunosuppression and radiotherapy (The CIRTED study) Peter N. Taylor (Cardiff) |
17:20 - 17:40 |
Teprotumumab - Ray Douglas (Los Angeles) |
17:40 - 18:00 |
Rituximab and other B cell targeting options - Mario Salvi (Milano) |
18:00 - 18:20 |
Tocilizumab - Jose V. Perez-Moreiras (Santiago de Compostela) |
18:20 - 18:50 |
lnteractive Discussion on Symposium 6 |
|
Chairmen: Luigi Bartalena (Varese) |
18:20 - 18:25 |
Chairperson's summary |
18:25 - 18:50 |
lnteractive discussion |
20:30 - 23:30 |
Network Dinner |
|
|
|
|
|
SCIENTIFIC PROGRAM Saturday, November the 9th, 2019 |
8:30 - 9:50 |
Symposium 7: ophthalmic perspectives |
|
Chairpersons: Marco Nardi (Pisa), Peter Dolman (Vancouver) |
8:30 - 8:50 |
Orbital decompression: does the approach matter? A review of the literature - Christoph Hintschich (Munich) |
8:50 - 9:10 |
Outcome measures for strabismus surgery - Branislav Stancovic (Be/grade) |
9:10 - 9:30 |
Treatment of eyelids and tear film alteration in GO - Kostas Boboridis (Thessaloniki) |
9:30 - 9:50 |
Nanotechnology applied to Graves' Orbitopathy: a potential alternative to more invasive medical and surgical treatments - Djon Paridaens (Rotterdam) |
9:55 - 10:55 |
Oral Presentations 3 |
|
Chairpersons: Goksun Ayvaz (Ankara), Antonella Boschi (Brussels) Coffee Break |
10:55 . 11:15 |
Coffee Break |
11:15 - 12:05 |
Patient Forum |
|
Chairpersons: Dan Morris (Cardiff), Petros Perros (Newcastle upon Tyne) |
11:15 - 12:05 |
The quality of life in GO and the impact of GO in public health - Katharina Ponto (Mainz) |
11:35 - 11:55 |
My life with GO - Janis Hickey (British Thyroid Foundation) |
11:55 - 12:15 |
lmplementing change for improving the care of patients with GO: the TEAMED paradigm - Co/in Dayan (Cardiff) |
12:15 - 12:35 |
Lecture |
|
Chairperson: Wilmar Wiersinga (Amsterdam) |
|
Quo vadis GO? - Marius Stan (USA) |
12:40 - 1:00 |
Closing Ceremony |